Endo International - M&A Summary and Business Overview

Medical ProductsCompany

Endo International M&A Summary

Endo International has acquired 17 companies, including 2 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 4 assets.

Endo International’s largest acquisition to date was in 2015, when it acquired Par Pharmaceutical Companies for $8.1B. It’s largest disclosed sale occurred in 2015, when it sold American Medical Systems to Boston Scientific for $1.6B. Endo International has acquired in 11 different US states, and 3 countries. The Company’s most targeted sectors include life science (69%) and medical products (32%).

Endo International Business Overview

Where is Endo International headquartered?

Endo International is headquartered in Dublin, Ireland.

What is Endo International’s revenue?

Endo International disclosed revenue of 2,903M USD for 2020 and 2,914M USD for 2019.

How many employees does Endo International have?

Endo International has 3,103 employees.

What sector is Endo International in?

Endo International is a medical products company.

When was Endo International founded?

Endo International was founded in 1920.

M&A Summary

  • M&A Total Activity20
    • M&A Buy Activity16
    • M&A Sell Activity4
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 11
  • M&A Advisors 9

Endo International

Endo International plc

Minerva House First Floor Simmonscourt Road Ballsbridge,
Dublin,
Ireland,
+353 1 268 2000
www.endo.com

Endo International is a pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, bladder cancer, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Endo International was incorporatted in 1920 and is based in Dublin, Ireland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # 14 1 - 1 - - 16
vol $18.0B $540M $35M $18.6B
Sell (0.0/yr) # 4 - - - - - 4
vol $1.9B $1.9B
  20

Most Recent M&A

Company Date Value Type
Nevakar Injectables - Six Development-Stage Product 2022-05-02 35M USD Divestiture
Bridgewater, New Jersey
BioSpecifics Technologies Corp. 2020-10-19 540M USD Add-on Acquisition
Wilmington, Delaware · www.biospecifics.com
Grupo Farmacéutico SOMAR 2017-07-05 124M USD Divestiture
Benito Juarez , Mexico · www.gruposomar.com
Litha Healthcare Group Ltd. 2017-02-28 - Divestiture
Midrand, South Africa · www.lithahealthcare.co.za
Par Pharmaceutical Companies, Inc. 2015-05-18 8.1B USD Add-on Acquisition
Woodcliff Lake, New Jersey · www.parpharm.com
American Medical Systems, Inc. 2015-03-02 1.6B USD Divestiture
Minnetonka, Minnesota · www.americanmedicalsystems.com
Auxilium Pharmaceuticals, Inc. 2015-01-29 2.6B USD Add-on Acquisition
Malvern, Pennsylvania · www.auxilium.com
Grupo Farmacéutico SOMAR 2014-07-24 - Add-on Acquisition
Benito Juarez , Mexico · www.gruposomar.com
DAVA Pharmaceuticals, Inc. 2014-06-24 575M USD Add-on Acquisition
Fort Lee, New Jersey · www.davapharma.com
HealthTronics, Inc. 2014-02-03 130M USD Divestiture
Austin, Texas · www.healthtronics.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 11 (69%) 15.1B (81%) 1 (25%) 124M (7%)
Medical Products 5 (31%) 3.5B (19%) 2 (50%) 1.7B (93%)
Healthcare Services - - 1 (25%) -
Total 16 $18.6B 4 $1.9B

By Geo

State/Country Buy Value Sell Value
United States 14 17.0B 2 1.7B
  New Jersey 3 8.7B - -
  New York 2 182M - -
  Minnesota 1 2.9B 1 1.6B
  Texas 1 223M 1 130M
  Massachusetts 1 370M - -
  Florida 1 225M - -
  Delaware 1 540M - -
  Colorado 1 95M - -
  California 1 - - -
  Alabama 1 1.2B - -
  Pennsylvania 1 2.6B - -
Mexico 1 - 1 124M
Canada 1 1.6B - -
  Quebec 1 1.6B - -
South Africa - - 1 -
Domestic - - - -
Cross-border 16 (100%) 18.6B (100%) 4 (100%) 1.9B (100%)
Total 16 $18.6B 4 $1.9B

Top M&A Advisors

Financial Deals
Deutsche Bank Corporate & Investment Banking
2
Lazard Ltd.
2
Morgan Stanley
1
Legal Deals
Skadden, Arps, Slate, Meagher & Flom
8
Torys LLP
1

Deal Values

buy # Total
> $1B 5 $16.4B
$100M to $1B 6 $2.1B
< $100M 3 $144M
TOTAL $18.6B
Largest Par Pharmaceutical Companies, Inc.
$8.1B (2015-05-18)
sell # Total
> $1B 1 $1.6B
$100M to $1B 2 $254M
TOTAL $1.9B
Largest American Medical Systems, Inc.
$1.6B (2015-03-02)

M&A Connections

Deals
Acquired from
Investor(s)
31%
5 (31%)
Strategic(s)
6%
1 (6%)
Divested to
Investor(s)
50%
2 (50%)
Strategic(s)
50%
2 (50%)

 Subscribe to unlock this and 201,053
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 192K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Endo International

Medical Products Companies , Ireland Companies